IBEX LTD (IBEX) Stock Fundamental Analysis
NASDAQ:IBEX - Nasdaq - BMG4690M1010 - Common Stock - Currency: USD
We assign a fundamental rating of 7 out of 10 to IBEX. IBEX was compared to 82 industry peers in the IT Services industry. IBEX scores excellent points on both the profitability and health parts. This is a solid base for a good stock. IBEX may be a bit undervalued, certainly considering the very reasonable score on growth These ratings could make IBEX a good candidate for value and quality investing.
1. Profitability
1.1 Basic Checks
In the past year IBEX was profitable.
In the past year IBEX had a positive cash flow from operations.
IBEX had positive earnings in each of the past 5 years.
IBEX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of IBEX (13.51%) is better than 95.12% of its industry peers.
Looking at the Return On Equity, with a value of 29.89%, IBEX belongs to the top of the industry, outperforming 93.90% of the companies in the same industry.
With an excellent Return On Invested Capital value of 18.65%, IBEX belongs to the best of the industry, outperforming 91.46% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for IBEX is significantly below the industry average of 21.60%.
The last Return On Invested Capital (18.65%) for IBEX is above the 3 year average (12.81%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.51% | ||
| ROE | 29.89% | ||
| ROIC | 18.65% |
ROA(3y)9.84%
ROA(5y)7.66%
ROE(3y)20.09%
ROE(5y)24.99%
ROIC(3y)12.81%
ROIC(5y)12.8%
1.3 Margins
IBEX has a Profit Margin of 6.93%. This is in the better half of the industry: IBEX outperforms 67.07% of its industry peers.
IBEX's Profit Margin has improved in the last couple of years.
Looking at the Operating Margin, with a value of 8.88%, IBEX is in the better half of the industry, outperforming 63.41% of the companies in the same industry.
In the last couple of years the Operating Margin of IBEX has grown nicely.
Looking at the Gross Margin, with a value of 30.89%, IBEX is in line with its industry, outperforming 42.68% of the companies in the same industry.
IBEX's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.88% | ||
| PM (TTM) | 6.93% | ||
| GM | 30.89% |
OM growth 3Y29.52%
OM growth 5Y35.17%
PM growth 3Y30.84%
PM growth 5Y17.25%
GM growth 3Y17.46%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so IBEX is creating value.
Compared to 1 year ago, IBEX has less shares outstanding
IBEX has less shares outstanding than it did 5 years ago.
The debt/assets ratio for IBEX is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.46 indicates that IBEX is not in any danger for bankruptcy at the moment.
The Altman-Z score of IBEX (4.46) is better than 68.29% of its industry peers.
IBEX has a debt to FCF ratio of 1.04. This is a very positive value and a sign of high solvency as it would only need 1.04 years to pay back of all of its debts.
With an excellent Debt to FCF ratio value of 1.04, IBEX belongs to the best of the industry, outperforming 82.93% of the companies in the same industry.
IBEX has a Debt/Equity ratio of 0.16. This is a healthy value indicating a solid balance between debt and equity.
IBEX has a better Debt to Equity ratio (0.16) than 65.85% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 1.04 | ||
| Altman-Z | 4.46 |
ROIC/WACC1.98
WACC9.42%
2.3 Liquidity
A Current Ratio of 1.67 indicates that IBEX should not have too much problems paying its short term obligations.
With a Current ratio value of 1.67, IBEX perfoms like the industry average, outperforming 53.66% of the companies in the same industry.
IBEX has a Quick Ratio of 1.67. This is a normal value and indicates that IBEX is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.67, IBEX is in line with its industry, outperforming 56.10% of the companies in the same industry.
The current and quick ratio evaluation for IBEX is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 |
3. Growth
3.1 Past
IBEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 34.22%, which is quite impressive.
The Earnings Per Share has been growing by 25.59% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 5.38% in the past year.
Measured over the past years, IBEX shows a small growth in Revenue. The Revenue has been growing by 6.66% on average per year.
EPS 1Y (TTM)34.22%
EPS 3Y18.32%
EPS 5Y25.59%
EPS Q2Q%17.14%
Revenue 1Y (TTM)5.38%
Revenue growth 3Y4.68%
Revenue growth 5Y6.66%
Sales Q2Q%10.99%
3.2 Future
Based on estimates for the next years, IBEX will show a quite strong growth in Earnings Per Share. The EPS will grow by 17.83% on average per year.
Based on estimates for the next years, IBEX will show a small growth in Revenue. The Revenue will grow by 6.63% on average per year.
EPS Next Y24.13%
EPS Next 2Y21.44%
EPS Next 3Y17.83%
EPS Next 5YN/A
Revenue Next Year7.46%
Revenue Next 2Y6.63%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 11.79, which indicates a very decent valuation of IBEX.
Based on the Price/Earnings ratio, IBEX is valued cheaply inside the industry as 87.80% of the companies are valued more expensively.
IBEX is valuated cheaply when we compare the Price/Earnings ratio to 27.51, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 9.47, the valuation of IBEX can be described as reasonable.
90.24% of the companies in the same industry are more expensive than IBEX, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of IBEX to the average of the S&P500 Index (35.58), we can say IBEX is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.79 | ||
| Fwd PE | 9.47 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IBEX indicates a rather cheap valuation: IBEX is cheaper than 91.46% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, IBEX is valued a bit cheaper than 67.07% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.07 | ||
| EV/EBITDA | 5.96 |
4.3 Compensation for Growth
IBEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The excellent profitability rating of IBEX may justify a higher PE ratio.
IBEX's earnings are expected to grow with 17.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.49
PEG (5Y)0.46
EPS Next 2Y21.44%
EPS Next 3Y17.83%
5. Dividend
5.1 Amount
No dividends for IBEX!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:IBEX (7/15/2025, 10:42:18 AM)
29.6
-0.33 (-1.1%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)
Earnings (Next)
Inst Owners93.39%
Inst Owner Change0%
Ins Owners9.78%
Ins Owner Change-10.21%
Market Cap395.75M
Analysts45.71
Price Target31.11 (5.1%)
Short Float %1.66%
Short Ratio1.17
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.71%
Min EPS beat(2)10.89%
Max EPS beat(2)14.54%
EPS beat(4)4
Avg EPS beat(4)10.27%
Min EPS beat(4)7.33%
Max EPS beat(4)14.54%
EPS beat(8)6
Avg EPS beat(8)4.12%
EPS beat(12)9
Avg EPS beat(12)12.36%
EPS beat(16)11
Avg EPS beat(16)11.12%
Revenue beat(2)2
Avg Revenue beat(2)3.78%
Min Revenue beat(2)2.45%
Max Revenue beat(2)5.12%
Revenue beat(4)3
Avg Revenue beat(4)2.25%
Min Revenue beat(4)-0.14%
Max Revenue beat(4)5.12%
Revenue beat(8)3
Avg Revenue beat(8)-0.13%
Revenue beat(12)3
Avg Revenue beat(12)-1.53%
Revenue beat(16)5
Avg Revenue beat(16)-1.36%
PT rev (1m)0%
PT rev (3m)17.31%
EPS NQ rev (1m)-2.78%
EPS NQ rev (3m)-5.41%
EPS NY rev (1m)1.18%
EPS NY rev (3m)1.98%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)2.88%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.49%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 11.79 | ||
| Fwd PE | 9.47 | ||
| P/S | 0.74 | ||
| P/FCF | 20.07 | ||
| P/OCF | 11.26 | ||
| P/B | 3.19 | ||
| P/tB | 3.52 | ||
| EV/EBITDA | 5.96 |
EPS(TTM)2.51
EY8.48%
EPS(NY)3.13
Fwd EY10.56%
FCF(TTM)1.47
FCFY4.98%
OCF(TTM)2.63
OCFY8.88%
SpS40.06
BVpS9.29
TBVpS8.4
PEG (NY)0.49
PEG (5Y)0.46
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 13.51% | ||
| ROE | 29.89% | ||
| ROCE | 25.63% | ||
| ROIC | 18.65% | ||
| ROICexc | 19.91% | ||
| ROICexgc | 21.22% | ||
| OM | 8.88% | ||
| PM (TTM) | 6.93% | ||
| GM | 30.89% | ||
| FCFM | 3.68% |
ROA(3y)9.84%
ROA(5y)7.66%
ROE(3y)20.09%
ROE(5y)24.99%
ROIC(3y)12.81%
ROIC(5y)12.8%
ROICexc(3y)17.21%
ROICexc(5y)17.42%
ROICexgc(3y)18.84%
ROICexgc(5y)20.06%
ROCE(3y)15.96%
ROCE(5y)15.95%
ROICexcg growth 3Y4.28%
ROICexcg growth 5Y9.56%
ROICexc growth 3Y7.35%
ROICexc growth 5Y13.69%
OM growth 3Y29.52%
OM growth 5Y35.17%
PM growth 3Y30.84%
PM growth 5Y17.25%
GM growth 3Y17.46%
GM growth 5YN/A
F-Score6
Asset Turnover1.95
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | 1.04 | ||
| Debt/EBITDA | 0.3 | ||
| Cap/Depr | 87.74% | ||
| Cap/Sales | 2.88% | ||
| Interest Coverage | 34.97 | ||
| Cash Conversion | 53.93% | ||
| Profit Quality | 53.13% | ||
| Current Ratio | 1.67 | ||
| Quick Ratio | 1.67 | ||
| Altman-Z | 4.46 |
F-Score6
WACC9.42%
ROIC/WACC1.98
Cap/Depr(3y)96.17%
Cap/Depr(5y)91.5%
Cap/Sales(3y)3.54%
Cap/Sales(5y)3.32%
Profit Quality(3y)72.8%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)34.22%
EPS 3Y18.32%
EPS 5Y25.59%
EPS Q2Q%17.14%
EPS Next Y24.13%
EPS Next 2Y21.44%
EPS Next 3Y17.83%
EPS Next 5YN/A
Revenue 1Y (TTM)5.38%
Revenue growth 3Y4.68%
Revenue growth 5Y6.66%
Sales Q2Q%10.99%
Revenue Next Year7.46%
Revenue Next 2Y6.63%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.55%
EBIT growth 3Y35.57%
EBIT growth 5Y44.18%
EBIT Next Year91.11%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-42.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-32.37%
OCF growth 3Y30.7%
OCF growth 5Y74.8%